Denali Therapeutics
DNLI
DNLI
118 hedge funds and large institutions have $1.09B invested in Denali Therapeutics in 2019 Q3 according to their latest regulatory filings, with 18 funds opening new positions, 38 increasing their positions, 25 reducing their positions, and 14 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
118
Holders Change
+4
Holders Change %
+3.51%
% of All Funds
2.59%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.07%
New
18
Increased
38
Reduced
25
Closed
14
Calls
$871K
Puts
$1.75M
Net Calls
-$883K
Net Calls Change
-$1.61M
Top Buyers
| 1 |
1
Vanguard Group
Malvern,
Pennsylvania
|
$93.4M |
| 2 |
CC
2
Casdin Capital
New York
|
$9.96M |
| 3 |
3
Dimensional Fund Advisors
Austin,
Texas
|
$6.1M |
| 4 |
4
Bank of New York Mellon
New York
|
$5.19M |
| 5 |
5
Millennium Management
New York
|
$1.56M |
